Amgen Inc (AMGN)
268.94
+6.20
(+2.36%)
USD |
NASDAQ |
Apr 19, 16:00
270.75
+1.80
(+0.67%)
After-Hours: 20:00
Amgen Total Return Level: 365.28 for April 18, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 18, 2024 | 365.28 |
April 17, 2024 | 367.12 |
April 16, 2024 | 369.30 |
April 15, 2024 | 369.12 |
April 12, 2024 | 371.58 |
April 11, 2024 | 375.36 |
April 10, 2024 | 370.42 |
April 09, 2024 | 375.86 |
April 08, 2024 | 374.25 |
April 05, 2024 | 375.29 |
April 04, 2024 | 372.70 |
April 03, 2024 | 381.50 |
April 02, 2024 | 383.99 |
April 01, 2024 | 393.49 |
March 28, 2024 | 395.27 |
March 27, 2024 | 398.02 |
March 26, 2024 | 391.72 |
March 25, 2024 | 390.40 |
March 22, 2024 | 383.94 |
March 21, 2024 | 385.02 |
March 20, 2024 | 379.60 |
March 19, 2024 | 377.76 |
March 18, 2024 | 376.61 |
March 15, 2024 | 373.79 |
March 14, 2024 | 377.50 |
Date | Value |
---|---|
March 13, 2024 | 383.69 |
March 12, 2024 | 384.45 |
March 11, 2024 | 382.81 |
March 08, 2024 | 380.57 |
March 07, 2024 | 379.34 |
March 06, 2024 | 384.52 |
March 05, 2024 | 384.60 |
March 04, 2024 | 388.41 |
March 01, 2024 | 389.72 |
February 29, 2024 | 380.68 |
February 28, 2024 | 385.73 |
February 27, 2024 | 387.16 |
February 26, 2024 | 398.12 |
February 23, 2024 | 402.02 |
February 22, 2024 | 396.46 |
February 21, 2024 | 394.07 |
February 20, 2024 | 394.14 |
February 16, 2024 | 394.41 |
February 15, 2024 | 401.87 |
February 14, 2024 | 400.15 |
February 13, 2024 | 400.71 |
February 12, 2024 | 406.16 |
February 09, 2024 | 401.59 |
February 08, 2024 | 406.74 |
February 07, 2024 | 408.15 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
199.95
Minimum
May 13 2019
447.72
Maximum
Feb 01 2024
306.03
Average
303.80
Median
Total Return Level Benchmarks
Gilead Sciences Inc | 89.96 |
Johnson & Johnson | 468.00 |
Eli Lilly and Co | 2147.17 |
Merck & Co Inc | 420.72 |
Vertex Pharmaceuticals Inc | 393.48 |